{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:23:52Z","timestamp":1780403032908,"version":"3.54.1"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cancer currently occurs in about 1 in 1000 pregnancies. Both active malignancy and pregnancy are individual risk factors for venous thromboembolism (VTE). The purpose of this systematic review\/meta\u2010analysis was to evaluate the rate of VTE in pregnant patients with active malignancy compared with pregnant patients without malignancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>Embase, Medline\/PubMed, Cochrane Database, and clinicaltrial.gov were search by a trained librarian from inception until June 2021, and limited to English and French language human studies using keywords related to pregnancy, neoplasm, and thrombosis. This study was prospectively registered with PROSPERO (CRD42021245886). Title, abstract, and full\u2010text review was performed using the Covidence data management system. Two authors reviewed the studies independently. Of the 3821 articles screened, seven cohort studies were included that reported VTE rate in patients with active malignancy in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 5928 individuals had active malignancy and pregnancy. Active malignancy in pregnancy significantly increased the odds of a VTE (odds ratio [OR] 6.8, 95% confidence interval [CI] 3.8\u201312.1). Specifically, patients with thyroid (OR 2.7, 95% CI 1.3\u20136.3), cervix (OR 6.6, 95% CI 2.4\u201318.0), or other gynecological (OR 10.6, 95% CI 4.4\u201325.8) cancers; Hodgkin's lymphoma (OR 8.7, 95% CI 3.3\u201323.4); or acute leukemia (OR 17.1, 95% CI 10.9\u201326.8) all had increased odds, whereas those with brain cancer (OR 6.1, 95% CI 0.4\u201398.2), breast cancer (OR 2.5, 95% CI 0.3\u201317.4), malignant melanoma (OR 5.5, 95% CI 0.3\u201388.1), or non\u2010Hodgkin's lymphoma (OR 3.2, 95% CI 0.8\u201312.9) malignancies did not have statistically significant increased odds for VTE. No studies reported whether prophylactic anticoagulation was used during pregnancy in this population; nor did they report timing in pregnancy of the VTE. The absolute risk for VTE in those with active malignancy was 0.9% compared with 0.2% in those without active malignancy in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Pregnancy with active malignancy confers a significant increased risk for VTE compared with pregnancy alone. Given this finding, prophylactic anticoagulation during pregnancy and postpartum could be considered in this patient population. Data are underpowered to make firm recommendations per cancer type.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aogs.14712","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T06:04:00Z","timestamp":1700114640000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk of venous thromboembolism in pregnant patients with active malignancy: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"103","author":[{"given":"Sara","family":"Folkins","sequence":"first","affiliation":[{"name":"Dalhousie University Medical School  Halifax Nova Scotia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Miller","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine Dalhousie University  Halifax Nova Scotia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-6662","authenticated-orcid":false,"given":"Christopher M.","family":"Nash","sequence":"additional","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine, Department of Obstetrics and Gynaecology Dalhousie University  Halifax Nova Scotia Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(15)30569-7"},{"key":"e_1_2_12_3_1","unstructured":"Thrombosis Canada.Clinical guide pregnancy: thromboprophylaxis 2020. Accessed February 2023.https:\/\/thrombosiscanada.ca\/clinicalguides\/"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1177"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0002-9378(03)00537-4"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2012.03475.x"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024802"},{"key":"e_1_2_12_8_1","volume-title":"Green Top Guideline No 37a: Reducing the Risk of Venous Thromboembolism during Pregnancy and Puerperium","author":"Nelson\u2010Piercy C","year":"2015"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002706"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16627"},{"key":"e_1_2_12_11_1","unstructured":"HigginsJPT GreenS.Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated march 2011].2011.The Cochrane Collaboration. Accessed February 20 2023.www.cochrane\u2010handbook.org"},{"key":"e_1_2_12_12_1","unstructured":"WellsGA SheaB O'ConnellD et\u00a0al.The Newcastle\u2010Ottawa Scale (NOS) for assessing the quality of nonrandomiazed studies in meta\u2010analysis. Accessed February 20 2023.https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2475-3"},{"key":"e_1_2_12_14_1","first-page":"380","article-title":"Risk of venous thromboembolic events in pregnant patients with cancer","volume":"29","author":"Bleau N","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12597"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3700-7"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1579188"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2019-0039"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07323.x"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6926(03)00021-5"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61348-2"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-469551"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605883"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0626"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-05042-x"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e368"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.14712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T18:18:16Z","timestamp":1744309096000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.14712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1111\/aogs.14712"],"URL":"https:\/\/doi.org\/10.1111\/aogs.14712","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"2023-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}